loading page

Ultrasound-guided totally implantable venous access ports placement via right brachiocephalic vein in pediatric population: a clinical debut
  • +6
  • Wei Ding,
  • Lu Qiu,
  • Tianyu Li,
  • Weiwei Su,
  • Qian Yu,
  • Tianshen Hu,
  • Chunxin Wang,
  • Chen Fan,
  • Weidong Wang
Wei Ding
Wuxi People's Hospital

Corresponding Author:[email protected]

Author Profile
Lu Qiu
Wuxi Children's Hospital
Author Profile
Tianyu Li
Wuxi Children's Hospital
Author Profile
Weiwei Su
Wuxi Children's Hospital
Author Profile
Qian Yu
The University of Chicago Medical Center
Author Profile
Tianshen Hu
The University of Texas Southwestern Medical Center
Author Profile
Chunxin Wang
Wuxi People's Hospital
Author Profile
Chen Fan
Wuxi People's Hospital
Author Profile
Weidong Wang
Wuxi People's Hospital
Author Profile

Abstract

Background and objectives: To investigate the feasibility and safety of ultrasound-guided totally implantable venous access ports (TIVAPs) via the right brachiocephalic vein (BCV) in pediatric patients. Methods: A single institutional retrospective review was performed on 35 pediatric patients with hematological malignancies who underwent TIVAPs implantation via ultrasound-guided right BCV approach from July 2018 to June 2021. Technical success rate, procedural information and TIVAP related complications were evaluated. Results: All the pediatric TIVAP devices were successfully implanted via right BCV access. Venous access was successful by first attempt in 32 children (91.42%); two cases (5.71%) required a second attempt; one patient (2.86%) required a third attempt. The mean procedural time was 44.63 ± 6.41 mins (range, 34-62 mins). No intraoperative complications occurred. The average TIVAP indwelling time was 563.51 ± 208.47 days (range, 193-1014 days) with a cumulative 19,723 catheter-days. The incidence of postoperative complications was 11.43% (4/35), corresponding to a rate of 0.20 complications per 1000 catheter-days. Two cases of local hematoma and two catheter dysfunctions occurred in three patients. No other complications such as wound dehiscence, delayed incision healing, catheter-related thrombosis (CRT), catheter malposition/fracture, surgical site infection, catheter-related bloodstream infection (CRBSI), pinch-off syndrome and drug extravasation were observed during follow-up. Conclusions: Ultrasound-guided right BCV access for TIVAPs placement in pediatric patients appears to be technically feasible, safe and effective. Further large-sample, prospective studies are warranted.
04 Apr 2022Submitted to Pediatric Blood & Cancer
04 Apr 2022Submission Checks Completed
04 Apr 2022Assigned to Editor
06 Apr 2022Reviewer(s) Assigned
17 Apr 2022Review(s) Completed, Editorial Evaluation Pending
19 Apr 2022Editorial Decision: Revise Minor
07 Jul 2022Submission Checks Completed
07 Jul 2022Assigned to Editor
07 Jul 20221st Revision Received
09 Jul 2022Reviewer(s) Assigned
14 Jul 2022Review(s) Completed, Editorial Evaluation Pending
14 Jul 2022Editorial Decision: Accept
26 Jul 2022Published in Pediatric Blood & Cancer. 10.1002/pbc.29911